VIG vs XLV
Vanguard Dividend Appreciation ETF vs Health Care Select Sector SPDR Fund
- • VIG has the lower expense ratio at 0.04% vs 0.08% for XLV.
- • XLV pays a higher dividend yield (1.60%).
Side-by-side metrics
| Metric | VIG | XLV |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.04% | 0.08% |
Dividend yield Trailing 12-month yield. | 1.51% | 1.60% |
AUM Assets under management — bigger funds are typically more liquid. | $129.46B | $40.60B |
YTD return | 8.91% | 5.74% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.75 | 0.51 |
P/E ratio | 26.66 | 29.12 |
Last price | $238.89 | $161.81 |
Inception | — | — |
Issuer | Vanguard | State Street |
VIG top holdings
| AVGO | Broadcom Inc | 5.39% |
| AAPL | Apple Inc | 4.55% |
| MSFT | Microsoft Corp | 4.26% |
| LLY | Eli Lilly and Co | 3.83% |
| JPM | JPMorgan Chase & Co | 3.31% |
| XOM | Exxon Mobil Corp | 2.66% |
| JNJ | Johnson & Johnson | 2.38% |
| V | Visa Inc Class A | 2.24% |
| WMT | Walmart Inc | 2.22% |
| CSCO | Cisco Systems Inc | 2.08% |
XLV top holdings
| LLY | Eli Lilly and Co | 16.48% |
| JNJ | Johnson & Johnson | 10.62% |
| ABBV | AbbVie Inc | 7.72% |
| UNH | UnitedHealth Group Inc | 6.56% |
| MRK | Merck & Co Inc | 5.51% |
| AMGN | Amgen Inc | 3.40% |
| TMO | Thermo Fisher Scientific Inc | 3.24% |
| ABT | Abbott Laboratories | 2.75% |
| GILD | Gilead Sciences Inc | 2.73% |
| ISRG | Intuitive Surgical Inc | 2.45% |
About VIG
VIG (Vanguard Dividend Appreciation ETF) is US companies with a record of growing dividends. Managed by Vanguard, the fund carries $129.5B in assets under management, an expense ratio of 0.04%, a dividend yield of 1.51%. Its largest holding is Broadcom Inc (AVGO), which represents 5.4% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 4.4%.
About XLV
XLV (Health Care Select Sector SPDR Fund) is S&P 500 health care sector. Managed by State Street, the fund carries $40.6B in assets under management, an expense ratio of 0.08%, a dividend yield of 1.60%. Its largest holding is Eli Lilly and Co (LLY), which represents 16.5% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.